Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial (2022)
Attributed to:
A Dose Reduction Immunobridging Study of two HPV vaccines in Tanzanian girls
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 10
Parent Publication: LANCET GLOBAL HEALTH
Issue: 10
ISSN: 2214-109X